Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers

BACKGROUND: It has been assumed that cancer patients, especially those undergoing chemotherapy, are at increased risk for infection and severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to the general population. After the first alert message from the local he...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Dominic, San Nicolò, Katja Olga, Alber, Monika, Mitterer, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838655/
https://www.ncbi.nlm.nih.gov/pubmed/33502609
http://dx.doi.org/10.1007/s00508-020-01807-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838655/
https://www.ncbi.nlm.nih.gov/pubmed/33502609
http://dx.doi.org/10.1007/s00508-020-01807-6

Ejemplares similares